Bionomics Limited

102 articles with Bionomics Limited

• Bionomics Limited Release: New BNC105 Biomarker Data To Be Presented At US Cancer Conference

  2/27/2015

• Bionomics Limited Begins Phase 1b Study With Anxiety Drug Bnc210

  2/2/2015

• Bionomics Limited Release: BNC101 Data To Be Presented At European Cancer Conference

  11/21/2014

• Bionomics Limited To Present BNC210 At Society For Neuroscience Meeting

  11/17/2014

• Bionomics Limited To Progress BNC210 In Clinical Trials

  11/11/2014

• Bionomics Limited Presents BNC105 Phase 2 Renal Cancer Trial Biomarker Data

  9/29/2014

• Bionomics Limited Receives $7.5M 2014 R&D Tax Incentive

  9/5/2014

• Bionomics Limited Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. Worth Up To $526 Million

  6/24/2014

• Bionomics Limited Features At American Association for Cancer Research Annual Meeting

  4/7/2014

• Bionomics Limited Sinks As Renal Cancer Drug Fails Key Phase 2 Test

  3/19/2014

• Bionomics Limited Wins Awards At Major BioPharma Asia Convention

  3/13/2014

• Bionomics Limited CEO To Present At ROTH Conference

  3/10/2014

• Bionomics Limited Release: BNC105 Phase I/II Trial Achieves A High Response Rate In Ovarian Cancer

  2/3/2014

• Bionomics Limited, Merck & Co., Inc. Strike $172 Million Pain Pact

  7/31/2013

• Bionomics Limited Completes Enrollment for BNC105 Phase II Renal Cancer Trial

  6/11/2013

• Bionomics Limited Release: Manufacture of BNC101 Commences at Lonza

  4/23/2013

• Bionomics Limited R&D Tax Incentive for FY2012

  1/15/2013

• Bionomics Limited Buys Eclipse Therapeutics for $10 Million

  9/17/2012

• Ironwood Pharmaceuticals, Bionomics Limited Pens Deal Worth Up to $345 Million

  1/5/2012

• Bionomics Limited Anti-Anxiety Drug Phase 1 Clinical Trials Successful Results

  3/30/2011